OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ATOS SE/  FR0000051732  /

Vienna Global Market
2024-04-25  9:15:43 AM Chg. -0.16 Volume Bid5:29:20 PM Ask5:29:20 PM Market Capitalization Dividend Y. P/E Ratio
1.83EUR -7.97% 1,000
Turnover: 1,825		 -Bid Size: - -Ask Size: - 210.68 mill.EUR - -
GlobeNewswire 04-15 Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...
GlobeNewswire 04-11 Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
GlobeNewswire 04-09 Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100%...
GlobeNewswire 04-01 Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-27 Calian Announces the Appointment of New President of Advanced Technologies
GlobeNewswire 03-25 Nametag Launches Self-Service Account Recovery Solution That Stops AI-Generated Deepfake Attacks
GlobeNewswire 03-19 Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Acce...
GlobeNewswire 03-18 Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
GlobeNewswire 03-12 Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Dir...
GlobeNewswire 03-06 Data from Atossa’s Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Can...
GlobeNewswire 02-22 Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
GlobeNewswire 01-16 New report reveals that 94% of global organizations have experienced email security incidents last y...
GlobeNewswire 01-09 Atossa Therapeutics Issues Letter to Shareholders
TeleTrader 01-03 Europe opens mixed with data, business in focus
TeleTrader 01-03 Airbus to purchase Atos' cyber security unit for $1.9B
GlobeNewswire 2023-12-13 Sodexo announces the composition of Pluxee’s future Board of Directors
GlobeNewswire 2023-12-04 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
GlobeNewswire 2023-11-20 Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
GlobeNewswire 2023-11-13 Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-09 Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
GlobeNewswire 2023-11-02 Schneider Electric finalizes acquisition of EcoAct
TeleTrader 2023-10-16 Atos chairman Meunier resigns
GlobeNewswire 2023-09-18 Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
GlobeNewswire 2023-08-30 Trusona and Carahsoft Partner to Aid Public Sector Compliance with Newly Enhanced Cybersecurity Requ...
GlobeNewswire 2022-03-23 Atossa Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference